Double-blind study of flunitrazepam (Ro 5-4200) and Mandrax.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004155:Diphenhydramine / Q000494:pharmacology*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005445:Flunitrazepam / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D008702:Methaqualone / Q000494:pharmacology*; D008875:Middle Aged; D011300:Preoperative Care; D011674:Pulse / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects; D013997:Time Factors
D014151:Anti-Anxiety Agents; D004338:Drug Combinations; D006993:Hypnotics and Sedatives; D005445:Flunitrazepam; D008702:Methaqualone; D004155:Diphenhydramine